{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T01:33:37Z","timestamp":1772674417121,"version":"3.50.1"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T00:00:00Z","timestamp":1485302400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Protein Cell"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s13238-016-0363-5","type":"journal-article","created":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T16:51:58Z","timestamp":1485363118000},"page":"225-229","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The chimeric Japanese encephalitis\/Dengue 2 virus protects mice from challenge by both dengue virus and JEV virulent virus"],"prefix":"10.1093","volume":"8","author":[{"given":"Jian","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiqiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhushi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianwu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,1,25]]},"reference":[{"key":"363_CR1","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/S0264-410X(97)00195-3","volume":"15","author":"TJ Chambers","year":"1997","unstructured":"Chambers TJ, Tsai TF, Pervikov Y, Monath TP (1997) Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting. Vaccine 15:1494\u20131502","journal-title":"Vaccine"},{"key":"363_CR2","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1128\/JVI.77.6.3655-3668.2003","volume":"77","author":"TJ Chambers","year":"2003","unstructured":"Chambers TJ, Liang Y, Droll DA, Schlesinger JJ, Davidson AD, Wright PJ, Jiang X (2003) Yellow fever virus\/dengue-2 virus and yellow fever virus\/dengue-4 virus chimeras: biological characterization, immunogenicity, and protection against dengue encephalitis in the mouse model. J Virol 77:3655\u20133668","journal-title":"J Virol"},{"key":"363_CR3","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/427780","volume":"191","author":"AP Durbin","year":"2005","unstructured":"Durbin AP, Whitehead SS, McArthur J, Perreault JR, Blaney JE Jr, Thumar B, Murphy BR, Karron RA (2005) rDEN4delta30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers. J Infect Dis 191:710\u2013718","journal-title":"J Infect Dis"},{"key":"363_CR4","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1128\/JVI.78.9.4761-4775.2004","volume":"78","author":"F Guirakhoo","year":"2004","unstructured":"Guirakhoo F, Pugachev K, Zhang Z, Myers G, Levenbook I, Draper K, Lang J, Ocran S, Mitchell F, Parsons M et al (2004) Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates. J Virol 78:4761\u20134775","journal-title":"J Virol"},{"key":"363_CR5","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4269\/ajtmh.1989.40.444","volume":"40","author":"SC Kliks","year":"1989","unstructured":"Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS (1989) Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg 40:444\u2013451","journal-title":"Am J Trop Med Hyg"},{"key":"363_CR6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1743-422X-9-135","volume":"9","author":"Y Li","year":"2012","unstructured":"Li Y, Counor D, Lu P, Duong V, Yu Y, Deubel V (2012) Protective immunity to Japanese encephalitis virus associated with anti-NS1 antibodies in a mouse model. Virol J 9:135","journal-title":"Virol J"},{"key":"363_CR7","doi-asserted-by":"crossref","first-page":"13694","DOI":"10.1128\/JVI.00931-13","volume":"87","author":"XF Li","year":"2013","unstructured":"Li XF, Deng YQ, Yang HQ, Zhao H, Jiang T, Yu XD, Li SH, Ye Q, Zhu SY, Wang HJ et al (2013) A chimeric dengue virus vaccine using Japanese encephalitis virus vaccine strain SA14-14-2 as backbone is immunogenic and protective against either parental virus in mice and nonhuman primates. J Virol 87:13694\u201313705","journal-title":"J Virol"},{"key":"363_CR8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virusres.2014.07.017","volume":"191","author":"Z Li","year":"2014","unstructured":"Li Z, Yang H, Yang J, Lin H, Wang W, Liu L, Zhao Y, Liu L, Zeng X, Yu Y et al (2014) Construction and preliminary investigation of a novel dengue serotype 4 chimeric virus using Japanese encephalitis vaccine strain SA14-14-2 as the backbone. Virus Res 191:10\u201320","journal-title":"Virus Res"},{"key":"363_CR9","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1099\/vir.0.80120-0","volume":"85","author":"EG Mathenge","year":"2004","unstructured":"Mathenge EG, del Parquet C, Funakoshi MY, Houhara S, Wong PF, Ichinose A, Hasebe F, Inoue S, Morita K (2004) Fusion PCR generated Japanese encephalitis virus\/dengue 4 virus chimera exhibits lack of neuroinvasiveness, attenuated neurovirulence, and a dual-flavi immune response in mice. J Gen Virol 85:2503\u20132513","journal-title":"J Gen Virol"},{"key":"363_CR10","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4269\/ajtmh.2008.79.678","volume":"79","author":"JH McArthur","year":"2008","unstructured":"McArthur JH, Durbin AP, Marron JA, Wanionek KA, Thumar B, Pierro DJ, Schmidt AC, Blaney JE Jr, Murphy BR, Whitehead SS (2008) Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity. Am J Trop Med Hyg 79:678\u2013684","journal-title":"Am J Trop Med Hyg"},{"key":"363_CR11","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0264-410X(98)00487-3","volume":"17","author":"TP Monath","year":"1999","unstructured":"Monath TP, Soike K, Levenbook I, Zhang ZX, Arroyo J, Delagrave S, Myers G, Barrett AD, Shope RE, Ratterree M et al (1999) Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates. Vaccine 17:1869\u20131882","journal-title":"Vaccine"},{"key":"363_CR12","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1073\/pnas.022652799","volume":"99","author":"AG Pletnev","year":"2002","unstructured":"Pletnev AG, Putnak R, Speicher J, Wagar EJ, Vaughn DW (2002) West Nile virus\/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy. Proc Natl Acad Sci USA 99:3036\u20133041","journal-title":"Proc Natl Acad Sci USA"},{"key":"363_CR13","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s00705-016-2817-8","volume":"161","author":"H Yang","year":"2016","unstructured":"Yang H, Li Z, Lin H, Wang W, Yang J, Liu L, Zeng X, Wu Y, Yu Y, Li Y (2016) A novel dengue virus serotype 1 vaccine candidate based on Japanese encephalitis virus vaccine strain SA14-14-2 as the backbone. Arch Virol 161:1517\u20131526","journal-title":"Arch Virol"},{"key":"363_CR14","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1016\/j.vaccine.2010.02.105","volume":"28","author":"Y Yu","year":"2010","unstructured":"Yu Y (2010) Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities. Vaccine 28:3635\u20133641","journal-title":"Vaccine"}],"container-title":["Protein & Cell"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13238-016-0363-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13238-016-0363-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13238-016-0363-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T11:44:03Z","timestamp":1676375043000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/proteincell\/article\/8\/3\/225\/6769762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,25]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["363"],"URL":"https:\/\/doi.org\/10.1007\/s13238-016-0363-5","relation":{},"ISSN":["1674-800X","1674-8018"],"issn-type":[{"value":"1674-800X","type":"print"},{"value":"1674-8018","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,25]]}}}